Optovue Receives FDA 510(k) Clearance of the RTVue XR FD-OCT

Less than a week after making a regulatory submission for a $1 million capital raise, prostate health company ProUroCare Medical, based in Eden Prairie, Minn., announced that it has secured market clearance for its diagnostic device.
MedCity News